Loading…

N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients

Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dys...

Full description

Saved in:
Bibliographic Details
Published in:Yonsei medical journal 2008, 49(4), , pp.625-631
Main Authors: Woo, Jeong Joo, Koh, Young Youp, Kim, Hee Joong, Chung, Joong Wha, Chang, Kyoung Sig, Hong, Soon Pyo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3
cites cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3
container_end_page 631
container_issue 4
container_start_page 625
container_title Yonsei medical journal
container_volume 49
creator Woo, Jeong Joo
Koh, Young Youp
Kim, Hee Joong
Chung, Joong Wha
Chang, Kyoung Sig
Hong, Soon Pyo
description Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients. Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3). Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p < 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p < 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups. Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.
doi_str_mv 10.3349/ymj.2008.49.4.625
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_332358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69475133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</originalsourceid><addsrcrecordid>eNpVkU2L1TAUhoMoznX0B7iRrMRNaz7apN0I4-DHwKAg4zqcJqfezPS2NUkvdOk_N_cDP1YnJO_75MBDyEvOSimr9u26uy8FY01ZtWVVKlE_IhvealWISurHZMNqLotat-qCPIvxnjGhORNPyQVvtGglUxvy60uRMOz8CAOdw0TfF2mdkY6Qgl8CJm_pjHPyDimMjqYtUtzDsEDy00innloIzoOlbo39Mtrj9SEZcY_Bp_WQcT4iRKR-pNaHsJ2O2IzAMcXn5EkPQ8QX53lJvn_8cHf9ubj9-unm-uq2sJVkqYDOCac70bCuQy601bKule6Y5V3tmhqAK1sxp1TfKN0rzUFi14LuAUTXO3lJ3py4Y-jNg_VmAn-cPybzEMzVt7sbI6WQdZOj707Reel26GxeM8Bg5uB3ENZj8f-X0W8zZm-E4rVoWQa8PgPC9HPBmMzOR4vDACNOSzSqrXR2I3OQn4I2TDEG7P98wpk5ODbZsTk4Nvlcmew4d179u93fxlmq_A08fqd7</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69475133</pqid></control><display><type>article</type><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><source>Open Access: PubMed Central</source><creator>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</creator><creatorcontrib>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</creatorcontrib><description>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients. Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3). Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p &lt; 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p &lt; 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups. Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</description><identifier>ISSN: 0513-5796</identifier><identifier>EISSN: 1976-2437</identifier><identifier>DOI: 10.3349/ymj.2008.49.4.625</identifier><identifier>PMID: 18729306</identifier><language>eng</language><publisher>Korea (South): Yonsei University College of Medicine</publisher><subject>Adult ; Aged ; Electrocardiography ; Female ; Heart Diseases - blood ; Heart Diseases - complications ; Heart Diseases - pathology ; Humans ; Liver Cirrhosis - blood ; Liver Cirrhosis - complications ; Liver Cirrhosis - pathology ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Original ; 의학일반</subject><ispartof>Yonsei Medical Journal, 2008, 49(4), , pp.625-631</ispartof><rights>Copyright © 2008 The Yonsei University College of Medicine 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</citedby><cites>FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615290/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615290/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18729306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001271364$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Woo, Jeong Joo</creatorcontrib><creatorcontrib>Koh, Young Youp</creatorcontrib><creatorcontrib>Kim, Hee Joong</creatorcontrib><creatorcontrib>Chung, Joong Wha</creatorcontrib><creatorcontrib>Chang, Kyoung Sig</creatorcontrib><creatorcontrib>Hong, Soon Pyo</creatorcontrib><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><title>Yonsei medical journal</title><addtitle>Yonsei Med J</addtitle><description>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients. Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3). Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p &lt; 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p &lt; 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups. Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</description><subject>Adult</subject><subject>Aged</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Heart Diseases - blood</subject><subject>Heart Diseases - complications</subject><subject>Heart Diseases - pathology</subject><subject>Humans</subject><subject>Liver Cirrhosis - blood</subject><subject>Liver Cirrhosis - complications</subject><subject>Liver Cirrhosis - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Original</subject><subject>의학일반</subject><issn>0513-5796</issn><issn>1976-2437</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkU2L1TAUhoMoznX0B7iRrMRNaz7apN0I4-DHwKAg4zqcJqfezPS2NUkvdOk_N_cDP1YnJO_75MBDyEvOSimr9u26uy8FY01ZtWVVKlE_IhvealWISurHZMNqLotat-qCPIvxnjGhORNPyQVvtGglUxvy60uRMOz8CAOdw0TfF2mdkY6Qgl8CJm_pjHPyDimMjqYtUtzDsEDy00innloIzoOlbo39Mtrj9SEZcY_Bp_WQcT4iRKR-pNaHsJ2O2IzAMcXn5EkPQ8QX53lJvn_8cHf9ubj9-unm-uq2sJVkqYDOCac70bCuQy601bKule6Y5V3tmhqAK1sxp1TfKN0rzUFi14LuAUTXO3lJ3py4Y-jNg_VmAn-cPybzEMzVt7sbI6WQdZOj707Reel26GxeM8Bg5uB3ENZj8f-X0W8zZm-E4rVoWQa8PgPC9HPBmMzOR4vDACNOSzSqrXR2I3OQn4I2TDEG7P98wpk5ODbZsTk4Nvlcmew4d179u93fxlmq_A08fqd7</recordid><startdate>20080830</startdate><enddate>20080830</enddate><creator>Woo, Jeong Joo</creator><creator>Koh, Young Youp</creator><creator>Kim, Hee Joong</creator><creator>Chung, Joong Wha</creator><creator>Chang, Kyoung Sig</creator><creator>Hong, Soon Pyo</creator><general>Yonsei University College of Medicine</general><general>연세대학교의과대학</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20080830</creationdate><title>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</title><author>Woo, Jeong Joo ; Koh, Young Youp ; Kim, Hee Joong ; Chung, Joong Wha ; Chang, Kyoung Sig ; Hong, Soon Pyo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Heart Diseases - blood</topic><topic>Heart Diseases - complications</topic><topic>Heart Diseases - pathology</topic><topic>Humans</topic><topic>Liver Cirrhosis - blood</topic><topic>Liver Cirrhosis - complications</topic><topic>Liver Cirrhosis - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Original</topic><topic>의학일반</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woo, Jeong Joo</creatorcontrib><creatorcontrib>Koh, Young Youp</creatorcontrib><creatorcontrib>Kim, Hee Joong</creatorcontrib><creatorcontrib>Chung, Joong Wha</creatorcontrib><creatorcontrib>Chang, Kyoung Sig</creatorcontrib><creatorcontrib>Hong, Soon Pyo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Yonsei medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woo, Jeong Joo</au><au>Koh, Young Youp</au><au>Kim, Hee Joong</au><au>Chung, Joong Wha</au><au>Chang, Kyoung Sig</au><au>Hong, Soon Pyo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients</atitle><jtitle>Yonsei medical journal</jtitle><addtitle>Yonsei Med J</addtitle><date>2008-08-30</date><risdate>2008</risdate><volume>49</volume><issue>4</issue><spage>625</spage><epage>631</epage><pages>625-631</pages><issn>0513-5796</issn><eissn>1976-2437</eissn><abstract>Cardiac dysfunction and hyperdynamic systemic circulation may be present in patients with cirrhosis. The purpose of this study was to identify relations between plasma levels of N-terminal-proBNP (NT-proBNP), reflecting early ventricular dysfunction, and the severity of liver disease and cardiac dysfunction in cirrhotic patients. Sixty-three cirrhotic patients and 15 controls (group 1) were enrolled in this study. Plasma levels of NT-proBNP were determined in echocardiographically examined patients, which were allocated to 1 of 3 groups according to Child-Pugh classification or into 2 groups, i.e., a compensated group without ascites (group 2) and decompensated group with ascites (group 3). Plasma NT-proBNP levels were significantly higher in cirrhotic patients (groups 2 and 3) than in age-matched controls (155.9 and 198.3 vs. 40.3 pg/mL, respectively, p &lt; 0.05). NT-proBNP levels were significantly increased in Child class C patients than in classes B and A (250.0 vs. 168.6 and 119.6 pg/mL, respectively, p &lt; 0.05). Left atrial dimension, wall thickness of left ventricle, and EF or E/E' were significantly increased, and EDT was prolonged in cirrhotic patients than in controls. Increased LVMI and decreased E/A ratio were noted in the group of patients with ascites as compared with the other groups. Plasma NT-proBNP levels were high in cirrhotic patients and are likely to be related to the severity of disease. Advanced cirrhosis is associated with advanced cardiac dysfunction, and NT-proBNP levels has predictive value for concomitant cardiac dysfunction and cirrhosis progression.</abstract><cop>Korea (South)</cop><pub>Yonsei University College of Medicine</pub><pmid>18729306</pmid><doi>10.3349/ymj.2008.49.4.625</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0513-5796
ispartof Yonsei Medical Journal, 2008, 49(4), , pp.625-631
issn 0513-5796
1976-2437
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_332358
source Open Access: PubMed Central
subjects Adult
Aged
Electrocardiography
Female
Heart Diseases - blood
Heart Diseases - complications
Heart Diseases - pathology
Humans
Liver Cirrhosis - blood
Liver Cirrhosis - complications
Liver Cirrhosis - pathology
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Original
의학일반
title N-terminal pro B-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=N-terminal%20pro%20B-type%20natriuretic%20peptide%20and%20the%20evaluation%20of%20cardiac%20dysfunction%20and%20severity%20of%20disease%20in%20cirrhotic%20patients&rft.jtitle=Yonsei%20medical%20journal&rft.au=Woo,%20Jeong%20Joo&rft.date=2008-08-30&rft.volume=49&rft.issue=4&rft.spage=625&rft.epage=631&rft.pages=625-631&rft.issn=0513-5796&rft.eissn=1976-2437&rft_id=info:doi/10.3349/ymj.2008.49.4.625&rft_dat=%3Cproquest_nrf_k%3E69475133%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-abd2d7b280bbe127c735567b0c1b5d85aa16c40d66f867f671a3eb9a7faa2bfd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69475133&rft_id=info:pmid/18729306&rfr_iscdi=true